- Home
- ALZN vs NUWE Comparison
ALZN vs NUWE Comparison
Compare ALZN & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- NUWE
- Stock Information
- Founded
- ALZN 2016
- NUWE 1999
- Country
- ALZN United States
- NUWE United States
- Employees
- ALZN N/A
- NUWE N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ALZN Health Care
- NUWE Health Care
- Exchange
- ALZN Nasdaq
- NUWE Nasdaq
- Market Cap
- ALZN 7.0M
- NUWE 5.9M
- IPO Year
- ALZN 2021
- NUWE N/A
- Fundamental
- Price
- ALZN $1.11
- NUWE $1.00
- Analyst Decision
- ALZN Strong Buy
- NUWE Strong Buy
- Analyst Count
- ALZN 1
- NUWE 1
- Target Price
- ALZN $32.00
- NUWE $17.00
- AVG Volume (30 Days)
- ALZN 174.7K
- NUWE 398.6K
- Earning Date
- ALZN 12-31-2024
- NUWE 11-11-2024
- Dividend Yield
- ALZN N/A
- NUWE N/A
- EPS Growth
- ALZN N/A
- NUWE N/A
- EPS
- ALZN N/A
- NUWE N/A
- Revenue
- ALZN N/A
- NUWE $8,969,000.00
- Revenue This Year
- ALZN N/A
- NUWE $3.52
- Revenue Next Year
- ALZN N/A
- NUWE $20.26
- P/E Ratio
- ALZN N/A
- NUWE N/A
- Revenue Growth
- ALZN N/A
- NUWE 3.66
- 52 Week Low
- ALZN $1.06
- NUWE $0.92
- 52 Week High
- ALZN $15.06
- NUWE $30.10
- Technical
- Relative Strength Index (RSI)
- ALZN 34.55
- NUWE 36.81
- Support Level
- ALZN $1.16
- NUWE $0.92
- Resistance Level
- ALZN $1.33
- NUWE $1.40
- Average True Range (ATR)
- ALZN 0.09
- NUWE 0.11
- MACD
- ALZN 0.01
- NUWE -0.02
- Stochastic Oscillator
- ALZN 17.86
- NUWE 16.67
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical device company. Its solutions includes Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.